- Home
- FTFT vs LYRA Comparison
FTFT vs LYRA Comparison
Compare FTFT & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- LYRA
- Stock Information
- Founded
- FTFT N/A
- LYRA 2005
- Country
- FTFT United States
- LYRA United States
- Employees
- FTFT N/A
- LYRA N/A
- Industry
- FTFT Business Services
- LYRA Medical/Dental Instruments
- Sector
- FTFT Consumer Discretionary
- LYRA Health Care
- Exchange
- FTFT Nasdaq
- LYRA Nasdaq
- Market Cap
- FTFT 11.0M
- LYRA 11.3M
- IPO Year
- FTFT N/A
- LYRA 2020
- Fundamental
- Price
- FTFT $2.21
- LYRA $7.58
- Analyst Decision
- FTFT
- LYRA Hold
- Analyst Count
- FTFT 0
- LYRA 1
- Target Price
- FTFT N/A
- LYRA $16.00
- AVG Volume (30 Days)
- FTFT 487.0K
- LYRA 27.2K
- Earning Date
- FTFT 11-18-2025
- LYRA 11-11-2025
- Dividend Yield
- FTFT N/A
- LYRA N/A
- EPS Growth
- FTFT N/A
- LYRA N/A
- EPS
- FTFT N/A
- LYRA N/A
- Revenue
- FTFT $2,368,206.00
- LYRA $770,000.00
- Revenue This Year
- FTFT N/A
- LYRA N/A
- Revenue Next Year
- FTFT N/A
- LYRA $123.83
- P/E Ratio
- FTFT N/A
- LYRA N/A
- Revenue Growth
- FTFT N/A
- LYRA N/A
- 52 Week Low
- FTFT $1.01
- LYRA $3.81
- 52 Week High
- FTFT $5.70
- LYRA $37.50
- Technical
- Relative Strength Index (RSI)
- FTFT 50.57
- LYRA 58.27
- Support Level
- FTFT $2.10
- LYRA $6.55
- Resistance Level
- FTFT $2.28
- LYRA $8.75
- Average True Range (ATR)
- FTFT 0.18
- LYRA 0.56
- MACD
- FTFT -0.01
- LYRA 0.18
- Stochastic Oscillator
- FTFT 65.22
- LYRA 52.13
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.